Surveillance of patients at risk of liver cancer: Expert opinions

The authors examine the current state of liver cancer surveillance, questioning why there is a lack of randomized trial evidence to support screening practices despite strong observational research. They highlight the challenges of false positives and low cancer incidence in low-prevalence populations, and advocate for risk-based surveillance tailored to individual patient profiles to potentially improve outcomes. The paper calls for stronger evidence and collaboration with screening committees to enhance liver cancer surveillance practices.